Literature DB >> 10879746

Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome.

P Hui1, V Parkash, A S Perkins, M L Carcangiu.   

Abstract

Placental site trophoblastic tumor (PSTT) is a neoplastic proliferation of intermediate trophoblasts that invades the myometrium at the placental site after a pregnancy. Less than 100 cases have been reported. Information of the sex assignment of the antecedent gestation is available in 21 cases: 18 of these were female. To explore this interesting phenomenon, we have determined the sex chromosome composition of the tumor tissue preserved in paraffin blocks for five new cases of this condition. The last documented gestational event included a normal vaginal delivery of female infants in three cases, normal vaginal delivery of an infant of unknown sex in one case and a molar gestation in one case. Using the X-linked human androgen receptor (AR) gene as a polymorphic marker, we showed that in all five cases the tumor had a likely XX chromosomal composition; and in four cases it was possible to determine that one of the X chromosomes was of paternal origin. In one case, the paternal X chromosome showed no polymorphism to either maternal X chromosomes. In addition, sensitive semi-nested PCR failed to show a human Y chromosome element in any of the five cases of PSTT. Overall, of 21 cases from the literature and 5 cases of ours, 89% (23 of 26) showed an XX genomic composition in PSTT, either by history or genetic analysis. These results suggest that most PSTT were derived from the antecedent female conceptus and were likely to have possessed a functional paternal X chromosome. Methylation status analysis at the AR locus was performed in the three PSTT in which the paternal X chromosome was identifiable. In two cases, the paternal AR locus was hypomethylated while the corresponding maternal locus was hypermethylated. The methylation status of other loci was not investigated. Collectively, sex chromosome analysis of five cases of PSTT with literature support suggests a unique genetic basis for the development of PSTT that involves the paternal X chromosome. Although largely speculative, an active paternal X chromosome may be of importance in the pathogenesis of PSTT.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10879746     DOI: 10.1038/labinvest.3780099

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  5 in total

1.  Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.

Authors:  Alfredo Fusco; Gennaro Chiappetta; Pei Hui; Ginesa Garcia-Rostan; Lauren Golden; Barbara K Kinder; Deborah A Dillon; Ada Giuliano; Anna Maria Cirafici; Massimo Santoro; Juan Rosai; Giovanni Tallini
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 2.  Placental site trophoblastic tumor.

Authors:  Nadereh Behtash; Mojgan Karimi Zarchi
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-16       Impact factor: 4.553

3.  Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin.

Authors:  Robert J Oldt; Robert J Kurman; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

Review 4.  A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors.

Authors:  Xuan Feng; Zhi Wei; Sai Zhang; Yan Du; Hongbo Zhao
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

5.  Imaging and Clinical Data of Placental Site Trophoblastic Tumor: A Case Report.

Authors:  Maryam Niknejadi; Firoozeh Ahmadi; Farnaz Akhbari
Journal:  Iran J Radiol       Date:  2016-04-16       Impact factor: 0.212

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.